TGF-β also contributes to therapy resistance and drives breast cancer cell stemness by increasing the expression of the lncRNA HOX antisense intergenic RNA (HOTAIR), which silences tumor suppressor gene expression in breast cancer cells. Here, TGFB1 is linked to neoplasm.